|
8491 |
You Can’t Always Get What You Want: The Influence of Choice on Nocebo and Placebo Responding
Enthalten in Annals of behavioral medicine Bd. 50, 15.1.2016, Nr. 3, date:6.2016: 445-451
|
|
|
|
8492 |
Yukmijihwang-tang for the treatment of xerostomia in the elderly: study protocol for a randomized, double-blind, placebo-controlled, two-center trial
Enthalten in Trials Bd. 14, 3.9.2013, Nr. 1, date:12.2013: 1-7
|
|
|
|
8493 |
Zahlreiche Biologika in der Pipeline
Enthalten in Hautnah / Dermatologie Bd. 35, 18.2.2019, Nr. 1, date:2.2019: 6-9
|
|
|
|
8494 |
ZED1227 – vielversprechende medikamentöse Therapie der Zöliakie?
Enthalten in Schweizer Gastroenterologie Bd. 2, 11.11.2021, Nr. 4, date:12.2021: 150-151
|
|
|
|
8495 |
Zeit im Zielbereich statt HbA1c
Enthalten in CME Bd. 17, 12.2.2020, Nr. 1-2, date:2.2020: 46
|
|
|
|
8496 |
Zejula® — Neue Chance bei platinsensiblem Ovarialkarzinom
Enthalten in Im Focus Onkologie Bd. 21, 10.7.2018, Nr. 7-8, date:7.2018: 78
|
|
|
|
8497 |
Zejula® — Neue Chance bei platinsensiblem Ovarialkarzinom
Enthalten in InFo Onkologie Bd. 21, 10.9.2018, Nr. 5, date:9.2018: 74
|
|
|
|
8498 |
Zhizhu Kuanzhong Capsule in treating patients with functional dyspepsia postprandial distress syndrome: study protocol for a multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial
Enthalten in Trials Bd. 23, 2.6.2022, Nr. 1, date:12.2022: 1-10
|
|
|
|
8499 |
Zibotentan in systemic sclerosis-associated chronic kidney disease: a phase II randomised placebo-controlled trial
Enthalten in Arthritis Research & Therapy Bd. 24, 1.6.2022, Nr. 1, date:12.2022: 1-13
|
|
|
|
8500 |
Zieleinlauf mit GLP-1-Analogon als Add-on
Enthalten in Info Diabetologie Bd. 12, 8.9.2018, Nr. 4, date:9.2018: 56
|
|
Administration
